Neither in unadjusted COX survival analysis (HR: 3.29; 95% CI: 2.02, 5.35; p < .001) nor adjusted for age, tumor stage, surgery, chemotherapy, radiotherapy, albumin (HR: 2.09; 95% CI: 1.26, 3.45; p = .004, Table 4), high IR combined with high inflammatory state were both identified as adverse prognostic factors affecting the survival of patients with malignant tumors of the female reproductive system. The gene discussed is ALB; the disease is cancer.